WEBVTT - Eli Lilly Given Emergency Use Authorization for COVID Treatment

0:00:00.040 --> 0:00:03.920
<v Speaker 1>It's Friday, November. I'm Oscar Ramirez from the Daily Dive

0:00:04.000 --> 0:00:08.360
<v Speaker 1>podcast in Los Angeles, and this is Reopening America. The

0:00:08.440 --> 0:00:11.360
<v Speaker 1>FDA this week gave the emergency use authorization to Eli

0:00:11.440 --> 0:00:15.400
<v Speaker 1>Lily for their monoclonal anybody COVID treatment. It is similar

0:00:15.400 --> 0:00:17.720
<v Speaker 1>to the treatment that President Trump received when he was sick,

0:00:17.960 --> 0:00:20.520
<v Speaker 1>and it is aimed at keeping mild cases from turning

0:00:20.520 --> 0:00:23.680
<v Speaker 1>more serious. The process of getting this treatment developed and

0:00:23.720 --> 0:00:26.680
<v Speaker 1>improved was difficult, and that the company also had to

0:00:26.680 --> 0:00:29.080
<v Speaker 1>deal with the pandemic at the same time. They had

0:00:29.080 --> 0:00:32.000
<v Speaker 1>a trim down their staff, work remotely in some cases,

0:00:32.320 --> 0:00:34.159
<v Speaker 1>and the chief of the lab how to use a

0:00:34.280 --> 0:00:36.480
<v Speaker 1>robot with an iPad attached to it so he could

0:00:36.479 --> 0:00:40.239
<v Speaker 1>patrol that lab. Peter loftus healthcare reporter at the Wall

0:00:40.280 --> 0:00:43.480
<v Speaker 1>Street Journal, joins us for how Eli Lily got it done.

0:00:43.680 --> 0:00:46.120
<v Speaker 1>Thanks for joining us, Peter, Thanks for having me on.

0:00:46.600 --> 0:00:50.160
<v Speaker 1>I wanted to talk about this drug from Eli Lily.

0:00:50.680 --> 0:00:53.760
<v Speaker 1>It's a COVID nineteen drug that is very similar to

0:00:53.840 --> 0:00:56.360
<v Speaker 1>the one that President Trump took when he was receiving treatment.

0:00:56.520 --> 0:01:01.760
<v Speaker 1>It's a anti body treatment and the FDAY just authorized

0:01:01.800 --> 0:01:04.120
<v Speaker 1>emergency use of it. Peter if you can help us

0:01:04.120 --> 0:01:06.959
<v Speaker 1>out tell us a little bit more about how this

0:01:07.040 --> 0:01:10.560
<v Speaker 1>drug works. And then the difficulty in actually manufacturing this

0:01:10.600 --> 0:01:14.479
<v Speaker 1>because Eli Lily had to also go through a shutdown

0:01:14.880 --> 0:01:18.280
<v Speaker 1>throughout the pandemic, and the way they changed their practices

0:01:18.319 --> 0:01:20.520
<v Speaker 1>to be able to still get this out is pretty amazing.

0:01:20.560 --> 0:01:24.040
<v Speaker 1>So Peter, tell us what we know about this drug. Sure,

0:01:24.319 --> 0:01:27.600
<v Speaker 1>So the drug I believe is pronounced them lenivum ev.

0:01:27.920 --> 0:01:32.080
<v Speaker 1>So this drug is called a monoclonal antibody, and it's

0:01:32.120 --> 0:01:36.200
<v Speaker 1>from Eli Lily, and it's something that's essentially an engineered

0:01:36.319 --> 0:01:40.360
<v Speaker 1>version of the immune system antibodies that are produced in

0:01:40.480 --> 0:01:43.440
<v Speaker 1>response to the coronavirus and so, and the way that

0:01:43.480 --> 0:01:46.520
<v Speaker 1>they developed it was they analyzed a blood sample from

0:01:46.560 --> 0:01:49.520
<v Speaker 1>an early survivor of COVID nineteen and they kind of

0:01:49.560 --> 0:01:52.840
<v Speaker 1>isolated what they thought were the most potent antibodies in

0:01:52.920 --> 0:01:55.920
<v Speaker 1>that blood sample, and then they basically clone them in

0:01:55.960 --> 0:02:00.480
<v Speaker 1>a factory to turn them into a pharmaceutical treatment. And

0:02:00.560 --> 0:02:03.840
<v Speaker 1>so what has happened over the past twenty four hours

0:02:03.960 --> 0:02:09.240
<v Speaker 1>is that the FDA has authorized the emergency use of

0:02:09.320 --> 0:02:13.000
<v Speaker 1>this antibody, and in particular in patients with mild to

0:02:13.080 --> 0:02:17.680
<v Speaker 1>moderate COVID nineteen, So people who are not in the hospital,

0:02:17.800 --> 0:02:21.880
<v Speaker 1>who aren't so severe, but they wanted to be prioritized

0:02:21.880 --> 0:02:24.560
<v Speaker 1>for people that that they may have mild to moderate

0:02:24.720 --> 0:02:27.960
<v Speaker 1>symptoms of COVID nineteen, but for certain reasons, they might

0:02:27.960 --> 0:02:31.720
<v Speaker 1>be at higher risk of worsening to severe disease where

0:02:31.720 --> 0:02:33.600
<v Speaker 1>they did end up in the hospital. And so that

0:02:33.639 --> 0:02:37.799
<v Speaker 1>would include people, say over the age of six, or

0:02:38.120 --> 0:02:41.400
<v Speaker 1>people who are overweight or have other chronic conditions that

0:02:41.480 --> 0:02:45.360
<v Speaker 1>might put them at higher risk. And tell me a

0:02:45.360 --> 0:02:47.679
<v Speaker 1>little bit about how they make this, because we're talking

0:02:47.680 --> 0:02:50.480
<v Speaker 1>about the difficulties and we'll get into how the workers

0:02:50.520 --> 0:02:52.960
<v Speaker 1>there had to adjust to all this. But these drugs

0:02:52.960 --> 0:02:56.519
<v Speaker 1>are grown in living cells, they're fed nutrients, they're put

0:02:56.560 --> 0:02:59.840
<v Speaker 1>in stainless steel tanks with ovary cells from Chinese hamster.

0:03:00.160 --> 0:03:02.639
<v Speaker 1>I mean, this is like crazy science stuff when you're

0:03:02.639 --> 0:03:06.240
<v Speaker 1>really talking about it. It's always fascinating to hear about

0:03:06.240 --> 0:03:09.720
<v Speaker 1>the source material for some of the ingredients that go

0:03:09.840 --> 0:03:14.320
<v Speaker 1>into two pharmaceuticals. I think one of the vaccines has

0:03:14.360 --> 0:03:17.880
<v Speaker 1>a component that's derived from I think tree bark. But

0:03:17.960 --> 0:03:21.440
<v Speaker 1>in any case, yeah, in this case, this lilli antibody,

0:03:21.680 --> 0:03:25.480
<v Speaker 1>this is actually a fairly common manufacturing method for this

0:03:25.560 --> 0:03:29.040
<v Speaker 1>type of drug, where it's grown in living cells and

0:03:29.400 --> 0:03:32.600
<v Speaker 1>they use a medium, They use a solution that sort

0:03:32.639 --> 0:03:37.320
<v Speaker 1>of allows the protein of interest to proliferate, to spread

0:03:37.360 --> 0:03:40.560
<v Speaker 1>and replicate. And so in this case, they're using the

0:03:40.640 --> 0:03:46.240
<v Speaker 1>solution that includes Chinese hamster ovary cells. And what they're

0:03:46.280 --> 0:03:49.600
<v Speaker 1>doing is they're in this solution. They start with a

0:03:49.640 --> 0:03:53.240
<v Speaker 1>small amount, but eventually that helps grow a very large

0:03:53.240 --> 0:03:56.280
<v Speaker 1>amount of the antibody. And it's all the same antibody,

0:03:56.320 --> 0:03:57.960
<v Speaker 1>but it's just a large amount of it. And so

0:03:58.560 --> 0:04:01.000
<v Speaker 1>they grow that in large amounts and then they purify

0:04:01.120 --> 0:04:03.800
<v Speaker 1>it and then package it and biles so that the

0:04:03.840 --> 0:04:08.080
<v Speaker 1>amount necessary in each file to treat one patient. And

0:04:08.120 --> 0:04:10.880
<v Speaker 1>now tell me a little bit about the process that

0:04:10.960 --> 0:04:13.640
<v Speaker 1>the company had to go through to actually do this.

0:04:13.680 --> 0:04:16.080
<v Speaker 1>We just talked about how complicated that process is and

0:04:16.120 --> 0:04:19.560
<v Speaker 1>how very specific it is. But at the plant where

0:04:19.560 --> 0:04:22.240
<v Speaker 1>they were making this production, you know, they had maybe

0:04:22.240 --> 0:04:24.160
<v Speaker 1>about sixty five workers to begin with. They had to

0:04:24.160 --> 0:04:26.960
<v Speaker 1>whittle that down to twenty or thirty, and then everybody's

0:04:27.000 --> 0:04:29.640
<v Speaker 1>working remotely. Like I said, they had to go through

0:04:29.680 --> 0:04:32.839
<v Speaker 1>this and make this drug for the pandemic. While the

0:04:32.880 --> 0:04:36.320
<v Speaker 1>pandemic was ongoing, you know, as everyone knows, a lot

0:04:36.360 --> 0:04:38.880
<v Speaker 1>of companies in all industries had to make a lot

0:04:38.880 --> 0:04:42.360
<v Speaker 1>of adjustments having people work from home, that sort of thing,

0:04:42.600 --> 0:04:44.599
<v Speaker 1>and so the drug companies have to do that too.

0:04:44.640 --> 0:04:47.200
<v Speaker 1>But then they're the ones who are actually working on

0:04:47.800 --> 0:04:51.680
<v Speaker 1>the drugs and vaccines that hopefully will be effective in

0:04:51.800 --> 0:04:54.160
<v Speaker 1>ending the pandemic, and so they have to do that

0:04:54.600 --> 0:04:57.919
<v Speaker 1>while taking these steps to prevent the spread of the

0:04:58.000 --> 0:05:01.240
<v Speaker 1>virus in the facility and to protect their workers. And

0:05:01.240 --> 0:05:05.360
<v Speaker 1>so in Lily's case, they're based in Indianapolis, and they

0:05:05.560 --> 0:05:08.760
<v Speaker 1>back in March, I think when all the lockdowns were starting,

0:05:09.000 --> 0:05:12.080
<v Speaker 1>they sent a significant majority of their employees to work

0:05:12.160 --> 0:05:14.760
<v Speaker 1>from home. So that did include a lot of office jobs,

0:05:14.800 --> 0:05:18.440
<v Speaker 1>but it also included scientists, people that work in research

0:05:18.520 --> 0:05:22.760
<v Speaker 1>labs that it included in some cases manufacturing workers. And

0:05:22.800 --> 0:05:25.440
<v Speaker 1>so the idea was to reduce the number of people

0:05:25.440 --> 0:05:28.800
<v Speaker 1>on site two as low as they could go. But

0:05:29.160 --> 0:05:31.560
<v Speaker 1>obviously they're still going to need some people on site

0:05:32.400 --> 0:05:35.039
<v Speaker 1>both to work on the COVID projects but also to

0:05:35.080 --> 0:05:38.880
<v Speaker 1>continue to make other drugs that Eli Lily makes, and

0:05:38.920 --> 0:05:41.279
<v Speaker 1>so they just tried to keep that at a lower number.

0:05:41.320 --> 0:05:45.039
<v Speaker 1>So that would be fewer people there to transmit the

0:05:45.120 --> 0:05:48.360
<v Speaker 1>virus or to be just to be exposed. And yeah,

0:05:48.480 --> 0:05:51.280
<v Speaker 1>they had to just make a lot of adjustments. One

0:05:51.360 --> 0:05:54.760
<v Speaker 1>part of the of the manufacturing process was taking what

0:05:54.880 --> 0:05:57.599
<v Speaker 1>was manufactured in these big steel tanks out of the

0:05:57.640 --> 0:06:00.680
<v Speaker 1>solution that I just talked about, and then putting the

0:06:00.680 --> 0:06:05.200
<v Speaker 1>final product into vials. And they bought this mobile lab.

0:06:05.680 --> 0:06:08.960
<v Speaker 1>It basically looks like a tractor trailer, but it's customized

0:06:09.360 --> 0:06:13.039
<v Speaker 1>to sit outside the factory because they felt this was

0:06:13.080 --> 0:06:14.800
<v Speaker 1>the quickest way to do this, and that was where

0:06:14.800 --> 0:06:18.400
<v Speaker 1>they actually put the drug into vials. And they found

0:06:18.440 --> 0:06:21.680
<v Speaker 1>that it took some practice and training to get the

0:06:21.720 --> 0:06:26.839
<v Speaker 1>employees used to working in close proximity, even with protective gear,

0:06:27.279 --> 0:06:29.599
<v Speaker 1>because you know, at that point, earlier in the year,

0:06:29.960 --> 0:06:33.960
<v Speaker 1>people had become so accustomed to keeping distant from everybody,

0:06:34.000 --> 0:06:37.000
<v Speaker 1>and they just people were a little leery about it. Yeah,

0:06:37.000 --> 0:06:39.160
<v Speaker 1>I mean even one of the doctors was rolling around

0:06:39.200 --> 0:06:41.600
<v Speaker 1>on a little robot with an iPad attached to it,

0:06:41.680 --> 0:06:44.480
<v Speaker 1>just so they can live stream things back and forth.

0:06:44.800 --> 0:06:46.760
<v Speaker 1>So what are the next steps for them? The US

0:06:46.839 --> 0:06:48.800
<v Speaker 1>is going to start distributing this as soon as it can.

0:06:48.880 --> 0:06:50.520
<v Speaker 1>I think they started saying as soon as this week

0:06:50.520 --> 0:06:52.760
<v Speaker 1>they were going to start distributing some of it. What's

0:06:52.800 --> 0:06:55.880
<v Speaker 1>next for them. The federal government has signed a supply

0:06:56.000 --> 0:07:00.000
<v Speaker 1>contract where they're buying three thousand doses of this little

0:07:00.000 --> 0:07:02.600
<v Speaker 1>the antibody, and because they're buying it, they're in a

0:07:02.680 --> 0:07:06.040
<v Speaker 1>customer essentially, they're going to allocate it. And so right now,

0:07:06.160 --> 0:07:09.080
<v Speaker 1>I think there's about eighty thou doses that are ready

0:07:09.120 --> 0:07:12.920
<v Speaker 1>to go in fairly short order, and the federal government

0:07:12.960 --> 0:07:16.200
<v Speaker 1>has already made decisions about which states they'll go to

0:07:16.800 --> 0:07:19.560
<v Speaker 1>or or in what amounts to each state, and they

0:07:19.600 --> 0:07:22.800
<v Speaker 1>make that decision by looking at where this community spread

0:07:22.840 --> 0:07:26.000
<v Speaker 1>is the is the worst basically, so states like Wisconsin

0:07:26.120 --> 0:07:29.600
<v Speaker 1>Illinois have very high rates right now, and so they're

0:07:29.600 --> 0:07:32.360
<v Speaker 1>getting a fairly high number of doses. And then Eli

0:07:32.440 --> 0:07:36.160
<v Speaker 1>Lily is increasing its manufacturing of the antibody, and so

0:07:36.280 --> 0:07:38.440
<v Speaker 1>they're going to try to have many more doses by

0:07:38.480 --> 0:07:40.440
<v Speaker 1>the end of the year. And it will be a

0:07:40.480 --> 0:07:43.400
<v Speaker 1>situation where, at least for the time being, the federal

0:07:43.440 --> 0:07:46.400
<v Speaker 1>government will see how many new doses are produced in

0:07:46.440 --> 0:07:48.960
<v Speaker 1>a given week and then parcel them out to various

0:07:49.040 --> 0:07:52.800
<v Speaker 1>parts of the country, and then state officials. Local health

0:07:52.840 --> 0:07:56.080
<v Speaker 1>departments would be in charge of figuring out, you know

0:07:56.120 --> 0:08:00.920
<v Speaker 1>what hospitals or say, infusion clinics should get the doses

0:08:01.240 --> 0:08:04.760
<v Speaker 1>and then eventually into patients. Well, I mean good news

0:08:04.800 --> 0:08:07.360
<v Speaker 1>on all that front. Hopefully we can get this squared

0:08:07.400 --> 0:08:10.520
<v Speaker 1>away very quickly and get it to people that really

0:08:10.560 --> 0:08:13.520
<v Speaker 1>need it and help them out that way. Peter loftus

0:08:13.840 --> 0:08:15.880
<v Speaker 1>healthcare reporter at the Wall Street Journal, thank you very

0:08:15.960 --> 0:08:21.840
<v Speaker 1>much for joining us my pleasure. I'm Oscar Ramirez and

0:08:21.840 --> 0:08:25.400
<v Speaker 1>this has been reopening America. Don't forget efforts to day's

0:08:25.400 --> 0:08:26.840
<v Speaker 1>big news stories. You can check me out on the

0:08:26.920 --> 0:08:30.080
<v Speaker 1>Daily Dive podcast every money through Friday, So follow us

0:08:30.080 --> 0:08:32.640
<v Speaker 1>on I Heart Radio or wherever you get your podcast